AstraZeneca PLC (AZN)
After hours:
| Previous close | 78.53 |
| Open | 78.69 |
| Bid | 78.57 x 300 |
| Ask | 78.62 x 400 |
| Day's range | 78.33 - 79.25 |
| 52-week range | 60.47 - 87.68 |
| Volume | |
| Avg. volume | 4,418,290 |
| Market cap | 245.097B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 38.15 |
| EPS (TTM) | 2.06 |
| Earnings date | 12 Nov 2024 |
| Forward dividend & yield | 1.49 (1.89%) |
| Ex-dividend date | 09 Aug 2024 |
| 1y target est | 90.89 |
GlobeNewswireInternational companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024
NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference (“dbVIC”) on Tuesday, September 24 and Wednesday, September 25, featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the US. Representatives from participating companies based in China, France, Hong Kong, Netherlands, Philippines, Portugal, Spain, Switzerland, and the United Kingdom will respo
Simply Wall St.Could The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?
AstraZeneca (LON:AZN) has had a rough month with its share price down 9.1%. But if you pay close attention, you might...
ZacksAZN Gets FDA Nod for Fasenra Label Expansion in Rare Disease
The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for the drug.
